ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.

Feng-Fei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.